SIC
TMDX icon

SJS Investment Consulting’s Transmedics TMDX Stock Holding History

SJS Investment Consulting’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53K Buy
23
+17
+283% +$1.44K ﹤0.01% 1875
2026
Q1 		$598 Buy
6
+2
+50% +$261 ﹤0.01% 1660
2025
Q4 		$487 Sell
4
-4
-50% -$502 ﹤0.01% 1531
2025
Q3 		$899 Buy
8
+1
+14% +$117 ﹤0.01% 1049
2025
Q2 		$939 Buy
+7
New +$769 ﹤0.01% 882

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

SJS Investment Consulting's TMDX Position: Q2 2026 in Review

SJS Investment Consulting increased its Transmedics (TMDX) stake by 283% in Q2 2026, buying an estimated $1.44K and bringing the position to 23 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

SJS Investment Consulting first reported a position in TMDX in Q2 2025 and has held it in 5 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • SJS Investment Consulting held 23 shares of Transmedics worth $1.53K as of Q2 2026.
  • SJS Investment Consulting bought 17 Transmedics shares in Q2 2026, an estimated $1.44K.
  • Transmedics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1875 holding.
  • SJS Investment Consulting first reported a position in Transmedics in Q2 2025 and has held it in 5 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.